Recently, an integrative approach encompassing analysis of transcriptomic datasets from ALS patients and transgenic TDP-43, SOD1, and FUS ALS mouse models demonstrated that oxidative phosphorylation was a major deregulated pathway in the disease, with an enrichment of proteins and inhibitors of mitochondrial Complex III and IV [107]. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.